Clinical Outcomes and Implications of Radioactive Iodine Therapy on Cancer-specific Survival in WHO Classification of FTC.
Genpeng LiZiyang YeTao WeiJingqiang ZhuZhihui LiJianyong LeiPublished in: The Journal of clinical endocrinology and metabolism (2024)
The RAIT can provide a CSS advantage for patients with wi-FTC who with N1-stage or M1-stage disease.